Pfizer’s Wyeth sues Novartis’ Sandoz over breast cancer drug patent

16-11-2021

Muireann Bolger

Pfizer’s Wyeth sues Novartis’ Sandoz over breast cancer drug patent

Molly Woodward / Shutterstock.com

Pfizer subsidiary Wyeth Pharmaceuticals has filed a suit jointly with Puma Biotechnology against Sandoz over a patent related to breast cancer drug, Nerlynx (neratinib).


Pfizer, Wyeth, Sandoz, Puma Biotech, Novartis, Nerlynx, big pharma

LSIPR